837
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Stability study of Prulifloxacin and Ulifloxacin in human plasma by HPLC–DAD

, , &
Pages 106-111 | Received 03 Dec 2014, Accepted 22 Dec 2014, Published online: 16 Feb 2015

Figures & data

Figure 1. Prulifloxacin, Ulifloxacin and Danofloxacin (IS) chemical structures.

Figure 1. Prulifloxacin, Ulifloxacin and Danofloxacin (IS) chemical structures.

Figure 2. Separation of standards solution mixture containing Prulifloxacin, Ulifloxacin and Danofloxacin (IS) (plasma sample, 20 μg/mL concentration level, 20 μL injected).

Figure 2. Separation of standards solution mixture containing Prulifloxacin, Ulifloxacin and Danofloxacin (IS) (plasma sample, 20 μg/mL concentration level, 20 μL injected).

Table 1. Chromatographic parameters.

Table 2. Within-assay and between-assay precision (RSD%), trueness (bias%) of the analytical method obtained from the analysis of QC samples.

Figure 3. Chromatograms obtained for Prulifloxacin and Ulifloxacin analyses: (a) human plasma used for the preparation of plasma calibration standards and QC samples, (b) human plasma sample fortified only with Danofloxacin (IS, at 20 μg/mL) and (c) a 25 μg/mL Prulifloxacin and Ulifloxacin plasma calibration sample with Danofloxacin (IS, at 20 μg/mL).

Figure 3. Chromatograms obtained for Prulifloxacin and Ulifloxacin analyses: (a) human plasma used for the preparation of plasma calibration standards and QC samples, (b) human plasma sample fortified only with Danofloxacin (IS, at 20 μg/mL) and (c) a 25 μg/mL Prulifloxacin and Ulifloxacin plasma calibration sample with Danofloxacin (IS, at 20 μg/mL).

Table 3. Recovery values of the analytical method obtained from the analysis of QC samples.

Figure 4. Stability curves at three concentration levels and three different storage temperatures for Prulifloxacin.

Figure 4. Stability curves at three concentration levels and three different storage temperatures for Prulifloxacin.

Table 4. Stability data at three concentration levels and three different storage temperatures for Prulifloxacin. Ulifloxacin was followed as principal metabolite and its concentration levels were reported.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.